Restless legs syndrome (RLS) significantly increases the risk of developing cardiovascular diseases, as well as favoring the appearance of other pathologies such as obesity or diabetes. In fact, and as confirmed by specialists who have attended the 'XXI Annual Meeting of the Spanish Sleep Society', patients with this disorder have up to 2.5 more chances of suffering heart problems and 1.5 more risk of hypertension.
Seven out of ten people with restless legs syndrome need to follow a continuous pharmacological treatment
SPI is a neurological disease that affects around 3% of Spaniards, especially women between the ages of 30 and 50, and is characterized by the fact that patients suffer from all kinds of discomfort in the lower extremities - pyrexia, cramps, tingling, pain-, especially during the night's rest, which prevents them from achieving quality sleep. In addition, this disorder also has symptoms during the day, which makes it difficult for those affected to lead a normal life. Normally these discomforts improve when moving the legs, hence the name.
Frequently, RLS becomes chronic, so seven out of ten patients need to undergo continued drug treatment. However, the experts of the Spanish Sleep Society, point out that several studies have shown that the drugs that are currently available to treat this disease, the dopamine agonists, they lose their effectiveness over time -which implies the reappearance or aggravation of symptoms-, and in some cases they have also presented adverse effects. Therefore, they warn of the need to continue research, in order to develop new drugs that guarantee the safety of a therapy that is necessary to continue for a long time, in addition to improving its long-term effectiveness.